ArticleSAGE open medical case reports2024
Squamous cell carcinoma arising from mature cystic teratoma of the ovary: A case report.
Article in SAGE open medical case reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Squamous cell carcinoma arising within a mature cystic teratoma of the ovary in a postmenopausal woman: A case report and literature review.Case reports in women's health · 2026Article
- Frequency and clinicopathological features of somatic neoplasms arising in ovarian mature teratomas: a single-center experience.Pathology oncology research : POR · 2026Article
- Squamous cell carcinoma arising from mature cystic teratoma of the ovary in a premenopausal women: A rare case report.International journal of surgery case reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mature cystic teratoma of the ovary (MCTO) is a type of common disease in clinic. However, the malignant transformation of MCTO occurred rarely, with many unexplained questions. To the best of our knowledge, owing to the rarity of squamous cell carcinoma (SCC) in MCTO, even though there are some previous research works concerning about this rare disease, further exploration and discussion is still necessary to reveal unknown aspects. We present a case of pathologically confirmed SCC in MCTO in a 54-year-old female patient, who underwent surgery and subsequent adjuvant chemotherapy. After the treatment, she recovered well and was followed up until now. SCC in MCTO occurred rarely; clinicians should abandon habitual concepts and make targeted management individually.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.